Indian CROs may feel the heat after local firm, Axis, is suspended
This article was originally published in Scrip
Executive Summary
India is set investigate the working of bio-availability and bio-equivalence study centres in the southern state of Andhra Pradesh, after a recent inquiry revealed significant irregularities in a study on the anticancer, exemestane, conducted by the clinical research organization(CRO), Axis Clinicals, there.